Menu Close

Video: Expert provides perspective on FDA approval of another experimental Alzheimer’s drug

The Food and Drug Administration (FDA) granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer’s disease something they haven’t had before: a medication that may slow the decline of memory and thinking.

Generated by Feedzy